Skip to Main Content
Table 3—

Retrospective database studies of insulin use

ReferencenPopulationAge (years)Follow-upHbA1cAdherence rate
Brown et al. (12) 102 HMO new start — 10 years — Persistence 79.6% at 24 months 
Morris et al. (7) 89 Scotland 16 ± 7 12 months 9.4 ± 1.7 33–86% days supply* 
     9.0 ± 1.5 87–116% days supply* 
Rajagopalan et al. (21) 27,274 all PBO 53 24 months — 62 ± 24% 
 1,323 new start     64 ± 24% 
ReferencenPopulationAge (years)Follow-upHbA1cAdherence rate
Brown et al. (12) 102 HMO new start — 10 years — Persistence 79.6% at 24 months 
Morris et al. (7) 89 Scotland 16 ± 7 12 months 9.4 ± 1.7 33–86% days supply* 
     9.0 ± 1.5 87–116% days supply* 
Rajagopalan et al. (21) 27,274 all PBO 53 24 months — 62 ± 24% 
 1,323 new start     64 ± 24% 
*

Days supply = number of tablet dispensed per prescribed number of times to be taken daily. HMO, health maintenance organization; PBO, pharmacy benefit organization.

Close Modal

or Create an Account

Close Modal
Close Modal